Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Shawn Donahue who wrote (5076)	12/6/2001 2:47:20 PM
From: Michael Young	Respond to of 52153

Interesting. I'd made a mental note recently to take a look at NEOL. Any idea if this fund manager knows his stuff? MIKE

To: Shawn Donahue who wrote (5076)	12/12/2001 6:15:14 AM
From: twentyfirstcenturyfox	Respond to of 52153

Hopefully not too O/T for this thread: Very recent news, in the Biological therapy or Immunotherapy, cancer treatment area, using BCG coupled with Interferon alpha. Ongoing Phase II and III Trial results (U of Iowa) to date indicate very positive improvement in treatment of certain cancers (bladder, prostate). Looking at the male demographics in the world (the boomers head into their 50's) and bearing in mind the demand for non-invasive clinical treatment, I am assessing developed and developing products in this field. Any feedback? Fox.